A Study to Evaluate SAGE-217 for Prevention of Relapse in Adult Participants With Major Depressive Disorder

PHASE3TerminatedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

August 6, 2019

Primary Completion Date

January 6, 2020

Study Completion Date

January 6, 2020

Conditions
Major Depressive Disorder
Interventions
DRUG

SAGE-217

SAGE-217 capsule

DRUG

Placebo

SAGE-217 matching placebo capsule

Trial Locations (46)

10017

Sage Investigational Site, New York

10128

Sage Investigational Site, New York

11432

Sage Investigational Site, Jamaica

14618

Sage Investigational Site, Rochester

18104

Sage Investigational Site, Allentown

20877

Sage Investigational Site, Gaithersburg

30022

Sage Investigational Site, Alpharetta

30030

Sage Investigational Site, Decatur

30328

Sage Investigational Site, Atlanta

30329

Sage Investigational Site, Atlanta

30331

Sage Investigational Site, Atlanta

32256

Sage Investigational Site, Jacksonville

32801

Sage Investigational Site, Orlando

33067

Sage Investigational Site, Coral Springs

33319

Sage Investigational Site, Lauderhill

38119

Sage Investigational Site, Memphis

44720

Sage Investigational Site, North Canton

48109

Sage Investigational Site, Ann Arbor

60634

Sage Investigational Site, Chicago

60712

Sage Investigational Site, Lincolnwood

70629

Sage Investigational Site, Lake Charles

72712

Sage Investigational Site, Bentonville

73106

Sage Investigational Site, Oklahoma City

75080

Sage Investigational Site, Richardson

75231

Sage Investigational Site, Dallas

76309

Sage Investigational Site, Wichita Falls

78737

Sage Investigational Site, Austin

87109

Sage Investigational Site, Albuquerque

89102

Sage Investigational Site, Las Vegas

90706

Sage Investigational Site, Bellflower

91403

Sage Investigational Site, Sherman Oaks

91945

Sage Investigational Site, Lemon Grove

92056

Sage Investigational Site, Oceanside

92078

Sage Investigational Site, San Marcos

92103

Sage Investigational Site, San Diego

92503

Sage Investigational Site, Riverside

92845

Sage Investigational Site, Garden Grove

92868

Sage Investigational Site, Orange

98201

Sage Investigational Site, Everett

454117

Sage Investigational Site, Dayton

02131

Sage Investigational Site, Boston

01844

Sage Investigational Site, Methuen

02472

Sage Investigational Site, Watertown

08009

Sage Investigational Site, Berlin

08002

Sage Investigational Site, Cherry Hill

08053

Sage Investigational Site, Marlton

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Biogen

INDUSTRY

NCT04007367 - A Study to Evaluate SAGE-217 for Prevention of Relapse in Adult Participants With Major Depressive Disorder | Biotech Hunter | Biotech Hunter